Haemonetics Corp is a Massachusetts corporation founded in 1971. It is a healthcare company that provides blood management solutions to its customers. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helps improve clinical outcomes and reduce costs for blood and plasma collectors, hospitals, and patients around the world. The company provide plasma collection systems and software which enable plasma fractionators to make pharmaceuticals and analytical devices for measuring hemostasis. It also makes blood processing systems and softwares for blood donation. Its products and services help prevent a transfusion to a patient who does not need one and provide the right blood product, at the right time, in the right dose to the patient who does. It serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors, and hospitals. Its product categories include: Plasma, Blood Center, Hospital, and Software Solutions. Plasma includes manufacture and market plasma collection devices and disposables. Blood Center includes automated blood component and manual whole blood collection systems to blood collection centers. Hospital : Loss of blood is common in many surgical procedures, including open heart, trauma, transplant, vascular, and orthopedic procedures, and the need for transfusion of oxygen-carrying red cells to make up for lost blood volume is necessary. Haemonetics offers a range of blood management solutions that improve a hospital's systems for acquiring blood, storing it in the hospital, and dispensing efficiently and perfectly. It also includes surgical blood salvage and blood demand diagnostic devices and consumables. Software Solutions: The company has a suite of integrated software solutions for improving efficiencies and helping ensure donor and patient safety. This includes solutions for blood drive planning, donor recruitment and retention, blood collection, component manufacturing and distribution, transfusion management, and remote blood allocation. The company market and sell their products to bio-pharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations and national health organizations through their own direct sales force (including full-time sales representatives and clinical specialists) as well as independent distributors. The Company's competitors include Terumo BCT, Sorin Biomedica and Fresenius SE & Co. KGaA. The products it manufactures and markets are subject to regulation by the Center of Biologics Evaluation and Research and the Center of Devices and Radiological Health of the United States Food and Drug Administration, and other non-United States regulatory bodies.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.